Related Articles
Expression of insulin-like growth factor-II mRNA-binding protein-3 as a marker for predicting clinical outcome in patients with esophageal squamous cell carcinoma
Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Survival‑associated factors of first‑line EGFR‑tyrosine kinase inhibitor responders and non‑responders in lung adenocarcinoma patients with common EGFR mutations
Surgery following neoadjuvant chemotherapy for non‑small‑cell lung cancer patients with unexpected persistent pathological N2 disease